Related references
Note: Only part of the references are listed.Saccular intracranial aneurysm: pathology and mechanisms
Juhana Frosen et al.
ACTA NEUROPATHOLOGICA (2012)
MMP-2/MMP-9 Plasma Level and Brain Expression in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke
Mar Hernandez-Guillamon et al.
BRAIN PATHOLOGY (2012)
Matrix metalloproteinase-9 concentration in the cerebral extracellular fluid of patients during the acute phase of aneurysmal subarachnoid hemorrhage
Asita Sarrafzadeh et al.
NEUROLOGICAL RESEARCH (2012)
Nuclear localization of Matrix metalloproteinases
Ferdinando Mannello et al.
PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY (2012)
Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm Rupture
David M. Hasan et al.
STROKE (2011)
Molecular Pathophysiology of Cerebral Hemorrhage Secondary Brain Injury
Jaroslaw Aronowski et al.
STROKE (2011)
Elevated Peripheral Neutrophils and Matrix Metalloproteinase 9 as Biomarkers of Functional Outcome Following Subarachnoid Hemorrhage
S. H. -Y. Chou et al.
TRANSLATIONAL STROKE RESEARCH (2011)
Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: A postmortem study
He Wu et al.
BRAIN RESEARCH (2010)
c-Jun N-Terminal Kinase Pathway Inhibition in Intracerebral Hemorrhage
Delphine Michel-Monigadon et al.
CEREBROVASCULAR DISEASES (2010)
Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases
Benedicte Cauwe et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Lewis B. Morgenstern et al.
STROKE (2010)
Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII?
Stephan A. Mayer et al.
STROKE (2009)
Incidence and 10-Year Survival of Intracerebral Hemorrhage in a Population-Based Registry
Simona Sacco et al.
STROKE (2009)
Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease
Miki Fujimura et al.
SURGICAL NEUROLOGY (2009)
Clinical significance of acute phase reaction in stroke patients
Tomasz Dziedzic
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Prothrombotic recombinant activated factor VII in intracerebral haemorrhage: FAST but not focused?
Julien Bogousslavsky et al.
LANCET NEUROLOGY (2008)
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
Stephan A. Mayer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse
Mark Grossetete et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage
Xiurong Zhao et al.
STROKE (2007)
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral Hemorrhage
Chanhung Z. Lee et al.
STROKE (2007)
Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation
Dong-In Sinn et al.
NEUROBIOLOGY OF DISEASE (2007)
Hematoma resolution as a target for intracerebral hemorrhage treatment:: Role for peroxisome proliferator-activated receptor γ in microglia/macrophages
Xiurong Zhao et al.
ANNALS OF NEUROLOGY (2007)
Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage
Emiri Tejima et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents
Gary A. Rosenberg et al.
BRAIN RESEARCH (2007)
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke
Anna Rosell et al.
STROKE (2006)
15d-prostaglandin J2 activates peroxisome proliferator-activated receptor-γ, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats
Xiurong Zhao et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
CM Overall et al.
BRITISH JOURNAL OF CANCER (2006)
Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement
ST Lee et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Recommendations for the management of intracranial haemorrhage - Part I: Spontaneous intracerebral haemorrhage
Thorsten Steiner et al.
CEREBROVASCULAR DISEASES (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Metalloproteinases: Mediators of pathology and regeneration in the CNS
VW Yong
NATURE REVIEWS NEUROSCIENCE (2005)
Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage
J Wang et al.
BRAIN (2005)
Multiple roles for MMPs and TIMPs in cerebral ischemia
LA Cunningham et al.
GLIA (2005)
New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies
J Aronowski et al.
NEUROLOGICAL RESEARCH (2005)
Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice
JEA Wells et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage
Y Silva et al.
STROKE (2005)
Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke
M Castellanos et al.
STROKE (2004)
Depressed cortical excitability and elevated matrix metalloproteinases in remote brain regions following intracerebral hemorrhage
S Mun-Bryce et al.
BRAIN RESEARCH (2004)
Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage -: Relationship to clinical and radiological outcome
J Alvarez-Sabín et al.
STROKE (2004)
MMP-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice
JP Tang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient
MH Yamani et al.
CIRCULATION (2003)
Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin) - An oxidative mechanism for restraining proteolytic activity during inflammation
XY Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage
S Abilleira et al.
JOURNAL OF NEUROSURGERY (2003)
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinages
C Power et al.
ANNALS OF NEUROLOGY (2003)
Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral Hemorrhage
JM Gebel et al.
STROKE (2002)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Pathophysiology of brain edema formation
GH Xi et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2002)
Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases
I Yana et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Share Paper
